Furthermore, high promoter methylation of STEAP1 correlated to high STEAP1 expression levels in tumor samples of CESC, COAD, ESCA, HNSC, KIRC, LUSC, and PAAD and low methylation levels was associated with lower STEAP1 expression in TGCT and UCEC. Here, STEAP1 is linked to neoplasm.